Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial

CONTEXT: Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic cardiomyopathy (ICM). Both autologous and allogeneic MSC therapies are possible; however, their safety and efficacy have not been compared. OBJECTIVE: To test whether allogeneic MSCs are as safe and effective as au...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JAMA
Huvudupphovsmän: Hare, Joshua M., Fishman, Joel E., Gerstenblith, Gary, DiFede Velazquez, Darcy L., Zambrano, Juan P., Suncion, Viky Y., Tracy, Melissa, Ghersin, Eduard, Johnston, Peter V., Brinker, Jeffrey A., Breton, Elayne, Davis-Sproul, Janice, Schulman, Ivonne H., Byrnes, John, Mendizabal, Adam M., Lowery, Maureen H., Rouy, Didier, Altman, Peter, Foo, Cheryl Wong Po, Ruiz, Phillip, Amador, Alexandra, Silva, Jose Da, McNiece, Ian K., Heldman, Alan W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2012
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762261/
https://ncbi.nlm.nih.gov/pubmed/23117550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2012.25321
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk